These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 8892346
21. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Wong A, Lüth HJ, Deuther-Conrad W, Dukic-Stefanovic S, Gasic-Milenkovic J, Arendt T, Münch G. Brain Res; 2001 Nov 30; 920(1-2):32-40. PubMed ID: 11716809 [Abstract] [Full Text] [Related]
22. Is there a spatial association between senile plaques and neurofibrillary tangles in Alzheimer's disease? Armstrong RA. Folia Neuropathol; 2005 Nov 30; 43(3):133-8. PubMed ID: 16245206 [Abstract] [Full Text] [Related]
23. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site. Dickson DW, Ksiezak-Reding H, Liu WK, Davies P, Crowe A, Yen SH. Acta Neuropathol; 1992 Nov 30; 84(6):596-605. PubMed ID: 1281953 [Abstract] [Full Text] [Related]
24. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain. Kida E, Choi-Miura NH, Wisniewski KE. Brain Res; 1995 Jul 10; 685(1-2):211-6. PubMed ID: 7583250 [Abstract] [Full Text] [Related]
25. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. Neurobiol Dis; 1996 Feb 10; 3(1):16-32. PubMed ID: 9173910 [Abstract] [Full Text] [Related]
26. Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease. Li YM, Dickson DW. Neurosci Lett; 1997 May 02; 226(3):155-8. PubMed ID: 9175590 [Abstract] [Full Text] [Related]
27. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease. Ishizawa K, Ksiezak-Reding H, Davies P, Delacourte A, Tiseo P, Yen SH, Dickson DW. Acta Neuropathol; 2000 Sep 02; 100(3):235-44. PubMed ID: 10965792 [Abstract] [Full Text] [Related]
28. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders. Kalaria RN, Galloway PG, Perry G. Neuropathol Appl Neurobiol; 1991 Jun 02; 17(3):189-201. PubMed ID: 1891063 [Abstract] [Full Text] [Related]
29. Distribution of apolipoprotein E in senile plaques in brains with Alzheimer's disease: investigation with the confocal laser scan microscope. Nishiyama E, Iwamoto N, Ohwada J, Arai H. Brain Res; 1997 Mar 07; 750(1-2):20-4. PubMed ID: 9098525 [Abstract] [Full Text] [Related]
30. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P. J Neural Transm (Vienna); 1996 Mar 07; 103(5):603-18. PubMed ID: 8811505 [Abstract] [Full Text] [Related]
31. Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Navarro A, Del Valle E, Astudillo A, González del Rey C, Tolivia J. Exp Neurol; 2003 Dec 07; 184(2):697-704. PubMed ID: 14769361 [Abstract] [Full Text] [Related]
32. Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease. Benzing WC, Mufson EJ. Exp Neurol; 1995 Apr 07; 132(2):162-71. PubMed ID: 7540552 [Abstract] [Full Text] [Related]
33. KP-1 is a marker for extraneuronal neurofibrillary tangles and senile plaques in Alzheimer diseased brains. Kobayashi K, Muramori F, Aoki T, Hayashi M, Miyazu K, Fukutani Y, Mukai M, Koshino F. Dement Geriatr Cogn Disord; 1998 Apr 07; 9(1):13-9. PubMed ID: 9469259 [Abstract] [Full Text] [Related]
34. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations. Sudo S, Shiozawa M, Cairns NJ, Wada Y. J Neurol Sci; 2005 Jul 15; 234(1-2):55-65. PubMed ID: 15946688 [Abstract] [Full Text] [Related]
35. Differential pattern of beta-amyloid, amyloid precursor protein and apolipoprotein E expression in cortical senile plaques. Thal DR, Glas A, Schneider W, Schober R. Acta Neuropathol; 1997 Sep 15; 94(3):255-65. PubMed ID: 9292695 [Abstract] [Full Text] [Related]
36. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K. Am J Pathol; 1994 Feb 15; 144(2):337-47. PubMed ID: 8311117 [Abstract] [Full Text] [Related]
37. Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer's disease. Münch G, Gasic-Milenkovic J, Arendt T. J Neural Transm Suppl; 2003 Feb 15; (65):63-71. PubMed ID: 12946049 [Abstract] [Full Text] [Related]
38. Microglia in cerebellar plaques in Alzheimer's disease. Mattiace LA, Davies P, Yen SH, Dickson DW. Acta Neuropathol; 1990 Feb 15; 80(5):493-8. PubMed ID: 2251906 [Abstract] [Full Text] [Related]
39. Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disease: relationship with the intellectual status in 29 cases. He Y, Delaère P, Duyckaerts C, Wasowicz M, Piette F, Hauw JJ. Acta Neuropathol; 1993 Feb 15; 86(1):109-16. PubMed ID: 8396836 [Abstract] [Full Text] [Related]
40. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. Richey PL, Siedlak SL, Smith MA, Perry G. Biochem Biophys Res Commun; 1995 Mar 17; 208(2):657-63. PubMed ID: 7695621 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]